Ctla4
Ctla4 cytotoxic T-lymphocyte-associated protein 4
CD; GSE; GRD4; ICOS; CD152; CTLA-4; IDDM12; CELIAC3; cytotoxic T-lymphocyte protein 4; CD152 isoform; celiac disease 3; cytotoxic T-lymphocyte antigen 4; cytotoxic T-lymphocyte-associated antigen 4; cytotoxic T-lymphocyte-associated serine esterase-4; cytotoxic T lymphocyte associated antigen 4 short spliced form; ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4; Ipilimumab; Yervoy; 477202-00-9; Ticilimumab (= tremelimumab); 745013-59-6;
ICOS
inducible T-cell co-stimulator
ICOS; inducible T-cell co-stimulator; inducible T-cell costimulator; activation inducible lymphocyte immunomediatory molecule; AILIM; CD278; inducible costimulator; activation-inducible lymphocyte immunomediatory molecule; CVID1; MGC39850;
Icosl
icos ligand
ICOSL; icos ligand; B7 H2; B7 homolog 2; B7 like protein Gl50; B7 related protein 1; B7-H2; B7-like protein Gl50; B7-related protein 1; B7H2; B7RP 1; B7RP-1; B7RP1; CD 275; CD275; CD275 antigen; GL 50; GL50; ICOS LG; ICOSL_HUMAN; ICOSLG; Inducible T cell co stimulator ligand; KIAA0653; LICOS; Transmembrane protein B7 H2 ICOS ligand; B7h; GI50; GL50-B; ICOS-L; Ly115l; AU044799; BG071784; mKIAA0653;
OXER1
oxoeicosanoid (OXE) receptor 1
OXER1; oxoeicosanoid (OXE) receptor 1; oxoeicosanoid receptor 1; 5 oxo ETE acid G protein coupled receptor 1; GPCR; GPR170; TG1019; G-protein coupled receptor 170; G-protein coupled receptor R527; G-protein coupled receptor TG1019; 5-oxo-ETE G-protein cou;